Membership
Tour
Register
Log in
Adam Mullick
Follow
Person
Carlsbad, CA, US
People
Overview
Industries
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Compounds and methods for modulating angiotensinogen expression
Patent number
11,447,521
Issue date
Sep 20, 2022
Ionis Pharmaceuticals, Inc.
Adam Mullick
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Compounds and methods for modulating angiotensinogen expression
Patent number
10,912,792
Issue date
Feb 9, 2021
Ionis Pharmaceuticals, Inc.
Adam Mullick
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Modulation of apolipoprotein CIII (ApoCIII) expression
Patent number
9,157,082
Issue date
Oct 13, 2015
ISIS Pharmaceuticals, Inc.
Adam Mullick
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Patents Applications
last 30 patents
Information
Patent Application
COMPOUNDS AND METHODS FOR REDUCING PLN EXPRESSION
Publication number
20240191232
Publication date
Jun 13, 2024
Ionis Pharmaceuticals, Inc.
Adam MULLICK
C07 - ORGANIC CHEMISTRY
Information
Patent Application
COMPOUNDS AND METHODS FOR MODULATING ANGIOTENSINOGEN EXPRESSION
Publication number
20220298200
Publication date
Sep 22, 2022
Ionis Pharmaceuticals, Inc.
Adam Mullick
C07 - ORGANIC CHEMISTRY
Information
Patent Application
ANGIOTENSIN II TYPE 1 RECEPTOR TARGETED OLIGONUCLEOTIDES AND USES T...
Publication number
20220243210
Publication date
Aug 4, 2022
Ionis Pharmaceuticals, Inc.
Adam Mullick
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
COMPOUNDS AND METHODS FOR MODULATING ANGIOTENSINOGEN EXPRESSION
Publication number
20220153775
Publication date
May 19, 2022
Ionis Pharmaceuticals, Inc.
Adam Mullick
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMPOUNDS AND METHODS FOR MODULATING ANGIOTENSINOGEN EXPRESSION
Publication number
20220000901
Publication date
Jan 6, 2022
Ionis Pharmaceuticals, Inc.
Adam Mullick
C07 - ORGANIC CHEMISTRY
Information
Patent Application
MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION
Publication number
20200056176
Publication date
Feb 20, 2020
Ionis Pharmaceuticals, Inc.
Adam Mullick
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
COMPOUNDS AND METHODS FOR MODULATING ANGIOTENSINOGEN EXPRESSION
Publication number
20190160090
Publication date
May 30, 2019
Ionis Pharmaceuticals, Inc.
Adam Mullick
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION
Publication number
20170268004
Publication date
Sep 21, 2017
Ionis Pharmaceuticals, Inc.
Adam Mullick
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION
Publication number
20160060625
Publication date
Mar 3, 2016
ISIS Pharmaceuticals, Inc.
Adam Mullick
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
MODULATION OF RENIN-ANGIOTENSIN SYSTEM (RAS) RELATED DISEASES BY AN...
Publication number
20150297629
Publication date
Oct 22, 2015
ISIS Pharmaceuticals, Inc.
Adam Mullick
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION
Publication number
20140128453
Publication date
May 8, 2014
ISIS Pharmaceuticals, Inc.
Adam Mullick
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...